Login
$HELP
$7.72 +$0.05 (0.71%) After hours

Company Executives

Officer Age In this role Source
Michael Halstead
Chief Executive Officer
Title from the Form 4 dated Sep 21, 2026
Not stated Not stated
Greg Cavers
Chief Financial Officer
56 Since 2020
6 years
Aaron Bartlone
Chief Operating Officer
59 Since 2023
3 years
Gabriel Fahel
Chief Legal Officer and Corporate Secretary
51 Since 2020
6 years
Paul Glavine Also a director
Chief Growth Officer and Director
37 Not stated
George Tziras
Chief Business Officer
45 Since 2023
3 years

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Board of Directors

From the 40-F annual report

Directors
7
serving now
Independent
1 of 1
stated in the proxy; 6 not stated
Average tenure
4.6 years
from year joined
Director Age On board Independent Committees Pay Source
Eric So
50 Not stated Not stated
Transactions Committee
Paid as CEO
Paul Glavine
37 Not stated Not stated None stated Not stated
Theresa Firestone
70 2021
5 years
Independent
Audit Committee Compensation Committee Governance and Nominating Committee
Not stated
Grant Froese
64 2020
6 years
Not stated
Audit Committee Compensation Committee
Not stated
Eric Hoskins
65 2020
6 years
Not stated
Audit Committee Governance and Nominating Committee Transactions Committee Scientific Advisory Committee
Not stated
Mark Lawson
53 2020
6 years
Not stated
Audit Committee Compensation Committee Governance and Nominating Committee Transactions Committee
Not stated
Freda Lewis-Hall
71 2026
this year
Not stated
Scientific Advisory Committee
Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No proxy statement on record

Related-party transactions come from the company’s proxy statement. Helus Pharma Inc. has not filed one with the SEC.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support